144 related articles for article (PubMed ID: 15534626)
1. Interethnic variability of ERCC2 polymorphisms.
King CR; Yu J; Freimuth RR; McLeod HL; Marsh S
Pharmacogenomics J; 2005; 5(1):54-9. PubMed ID: 15534626
[TBL] [Abstract][Full Text] [Related]
2. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population.
Yin J; Vogel U; Ma Y; Qi R; Sun Z; Wang H
Cancer Genet Cytogenet; 2007 May; 175(1):47-51. PubMed ID: 17498557
[TBL] [Abstract][Full Text] [Related]
3. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
5. ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis.
Lu X; Xiao S; Jin C; van der Straaten T; Li X
J Clin Lab Anal; 2012 Jan; 26(1):10-5. PubMed ID: 24833529
[TBL] [Abstract][Full Text] [Related]
6. ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.
Benhamou S; Sarasin A
Am J Epidemiol; 2005 Jan; 161(1):1-14. PubMed ID: 15615908
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China.
Shen M; Berndt SI; Rothman N; Demarini DM; Mumford JL; He X; Bonner MR; Tian L; Yeager M; Welch R; Chanock S; Zheng T; Caporaso N; Lan Q
Int J Cancer; 2005 Sep; 116(5):768-73. PubMed ID: 15849729
[TBL] [Abstract][Full Text] [Related]
9. Frequency distribution of DNA repair genes ERCC1 and ERCC2 polymorphisms in South Indian healthy population.
Rao KS; SureshKumar S; Umamaheswaran G; Paul A; Dubashi B; Gunaseelan K; Dkhar SA
Environ Toxicol Pharmacol; 2014 Sep; 38(2):480-8. PubMed ID: 25155628
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of associations between ERCC2 Lys751Gln/Asp312Asn polymorphisms and risk of non- Hodgkin lymphoma.
Zhou JY; He LW; Liu J; Yu HL; Wei M; Ma WL; Shi R
Asian Pac J Cancer Prev; 2014; 15(21):9347-53. PubMed ID: 25422223
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer.
Pabalan N; Francisco-Pabalan O; Sung L; Jarjanazi H; Ozcelik H
Breast Cancer Res Treat; 2010 Nov; 124(2):531-41. PubMed ID: 20379847
[TBL] [Abstract][Full Text] [Related]
12. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk.
Kuschel B; Chenevix-Trench G; Spurdle AB; Chen X; Hopper JL; Giles GG; McCredie M; Chang-Claude J; Gregory CS; Day NE; Easton DF; Ponder BA; Dunning AM; Pharoah PD
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1828-31. PubMed ID: 16030124
[TBL] [Abstract][Full Text] [Related]
13. ERCC2/XPD gene polymorphisms and cancer risk.
Benhamou S; Sarasin A
Mutagenesis; 2002 Nov; 17(6):463-9. PubMed ID: 12435843
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphisms of DNA repair genes ERCC2 and XRCC1 in populations of Russia].
Khrunin AV; Firsov SIu; Limborskaia SA
Genetika; 2011 Nov; 47(11):1565-8. PubMed ID: 22332413
[TBL] [Abstract][Full Text] [Related]
15. The polymorphism of DNA repair gene ERCC2/XPD Arg156Arg and susceptibility to breast cancer in a Chinese population.
Yin J; Liang D; Vogel U; Chang Y; Liu Z; Yue L; Sun X; Qi R; Song T
Biochem Genet; 2009 Aug; 47(7-8):582-90. PubMed ID: 19466538
[TBL] [Abstract][Full Text] [Related]
16. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphisms in ERCC1 and ERCC2/XPD with risk of chronic benzene poisoning in a Chinese occupational population.
Xiao S; Gao L; Liu Y; Yu T; Jin C; Pan L; Zhu G; Lu X
Mutat Res; 2013 Feb; 751(1):52-8. PubMed ID: 23147699
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
[TBL] [Abstract][Full Text] [Related]
20. Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
Lee SA; Lee KM; Park WY; Kim B; Nam J; Yoo KY; Noh DY; Ahn SH; Hirvonen A; Kang D
Exp Mol Med; 2005 Apr; 37(2):86-90. PubMed ID: 15886521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
